[go: up one dir, main page]

EP3433349B1 - Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices - Google Patents

Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices Download PDF

Info

Publication number
EP3433349B1
EP3433349B1 EP17716972.9A EP17716972A EP3433349B1 EP 3433349 B1 EP3433349 B1 EP 3433349B1 EP 17716972 A EP17716972 A EP 17716972A EP 3433349 B1 EP3433349 B1 EP 3433349B1
Authority
EP
European Patent Office
Prior art keywords
detergent composition
composition
fact
total weight
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP17716972.9A
Other languages
German (de)
French (fr)
Other versions
EP3433349A1 (en
Inventor
GaƩtan Rauwel
Jacques Criquelion
Bertrand Letartre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ecolab USA Inc
Original Assignee
Ecolab USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ecolab USA Inc filed Critical Ecolab USA Inc
Priority to PL17716972T priority Critical patent/PL3433349T3/en
Publication of EP3433349A1 publication Critical patent/EP3433349A1/en
Application granted granted Critical
Publication of EP3433349B1 publication Critical patent/EP3433349B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38627Preparations containing enzymes, e.g. protease or amylase containing lipase
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • C11D3/33Amino carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D7/00Compositions of detergents based essentially on non-surface-active compounds
    • C11D7/22Organic compounds
    • C11D7/32Organic compounds containing nitrogen
    • C11D7/3245Aminoacids
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D2111/00Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
    • C11D2111/10Objects to be cleaned
    • C11D2111/14Hard surfaces
    • C11D2111/20Industrial or commercial equipment, e.g. reactors, tubes or engines

Definitions

  • the present invention relates to the use of enzymatic detergent compositions for the automatic cleaning of surgical and / or medical instruments and / or apparatus.
  • Dr. Weigert has developed the neodisherĀ® SYSTEM ALPHA which is composed of two distinct highly concentrated components, namely an enzymatic component, the neodisherĀ® SystemAct, and an alkaline component, the neodisherĀ® SystemClean.
  • the enzyme component contains a subtilisin while the alkaline component contains triethanolamine and methylglycine diacetic acid (MGDA).
  • MGDA methylglycine diacetic acid
  • the patent US 7,723,281 describes a detergent composition comprising a stabilized enzyme system.
  • This enzymatic system comprises at least one enzyme but may include several, such as a protease, an amylase, a lipase, a gluconase, a cellulase, a peroxidase or a mixture thereof, as well as a chelating agent.
  • the stabilizing effect is obtained by incorporating an amine, in particular an antimicrobial, and an acid in a specific molar ratio.
  • the concentrated aqueous detergent composition of the invention does not present the problems of enzymatic stability encountered in the enzymatic compositions of the prior art containing alkanolamines.
  • the tri-enzymatic cocktail of the concentrated aqueous detergent composition of the invention will simultaneously hydrolyze the three targets and thus facilitate detergency.
  • the absence of alkanolamine makes it possible to formulate the detergent composition used in accordance with the invention in a very concentrated manner.
  • the water content of the concentrated aqueous detergent composition can be reduced up to 25% by weight relative to the total weight of the composition without having to add significant amounts of third-solvent, impact the stability of the enzymes and harm cleaning efficiency.
  • the composition used in accordance with the invention advantageously has a subtilisin content of 0.5 to 15% by weight relative to the total weight of the composition, preferably from 1 to 10% by weight relative to the total weight of the composition, preferably from 1 to 5% by weight relative to the total weight of the composition, more preferably around 3% by weight. relative to the total weight of the composition.
  • the lipase content is advantageously from 0.05 to 2% by weight relative to the total weight of the composition, preferably from 0.5 to 1.5% by weight relative to the total weight of the composition, more preferably from about 1% by weight relative to the total weight of the composition.
  • the amylase content is advantageously from 0.05 to 2% by weight relative to the total weight of the composition, preferably from 0.5 to 1.5% by weight relative to the total weight of the composition, more preferably from about 1% by weight relative to the total weight of the composition.
  • the biodegradable chelating agent is chosen from methylglycine diacetic acid (MGDA) and an iminodisuccinate (IDS), in particular the tetrasodium iminodisuccinate.
  • the biodegradable chelating agent is methylglycine diacetic acid (MGDA).
  • MGDA methylglycine diacetic acid
  • the chelating agent used in the present invention is not only used for softening water but also for complexing in a particularly effective way metal ions bi- and trivalent, in particular Ca 2+ , Fe 3+ , Fe 2+ and Cu 2+ , contained in the protein residues typically found on surgical and / or medical instruments. These chelating agents seem to sequester these metal ions, which destabilizes the tertiary structure of proteins and makes them more easily hydrolyzable.
  • the composition used in accordance with the invention advantageously has a content of biodegradable chelating agent of 10 to 50% by weight relative to the total weight of the composition, preferably from 20 to 40% by weight relative to the total weight of the composition, more preferably from 25 to 35% by weight relative to the total weight of the composition, more preferably still around 30% by weight relative to the total weight of the composition.
  • the concentrated aqueous detergent composition is advantageously free from any non-biodegradable chelating agent, in particular ethylene-diamine-tetraacetic acid (EDTA), diethylene-triamine-pentaacetic acid. (DTPA), phosphates and polyphosphates.
  • EDTA ethylene-diamine-tetraacetic acid
  • DTPA diethylene-triamine-pentaacetic acid
  • phosphates diethylene-triamine-pentaacetic acid.
  • polyphosphates phosphates
  • the concentrated aqueous detergent composition is also free from any chelating agent classified as reprotoxic such as nitrilotriacetic acid and its sodium salt (NTA).
  • the concentrated aqueous detergent composition is also free from alkali and alkaline earth hydroxides.
  • the water content of the concentrated detergent composition used in accordance with the invention is advantageously from 10 to 50% by weight relative to the total weight of the composition, preferably from 15 to 45% by weight relative to the total weight of the composition , more preferably from 20 to 40% by weight relative to the total weight of the composition and more preferably still from 25 to 40% by weight relative to the total weight of the composition.
  • the concentrated detergent composition may also contain a third solvent such as a polyol.
  • suitable polyols include alkylene glycols such as ethylene glycol, propylene glycol and glycerin (1,2,3-propanetriol).
  • the third solvent is glycerin.
  • Glycerin has the advantage of not only serving as a third solvent but also of stabilizing the enzymes.
  • the content of third-solvent is advantageously from 5 to 50% by weight relative to the total weight of the composition, preferably from 10 to 40% by weight relative to the total weight of the composition, more preferably from 13 to 25% by weight. weight relative to the total weight of the composition.
  • the concentrated detergent composition used in accordance with the invention may also comprise one or more nonionic surfactants.
  • the nonionic surfactant (s) may in particular be chosen from alkoxylated nonionic surfactants and alkylpolyglucosides.
  • the alkoxylated nonionic surfactants are advantageously chosen from alkoxylated nonionic surfactants, in particular from alkoxylated fatty alcohols, in particular ethoxylated and / or propoxylated, and EO-PO block copolymers.
  • the nonionic surfactant (s) are chosen from alkylpolyglucosides, preferably it is a C7 alkylpolyglucoside. This alkylpolyglucoside indeed brings the triple advantage of playing a stabilizing role, of bringing a wetting effect favorable to detergency and a non-foaming character compatible with an application in washer-disinfector.
  • the content of nonionic surfactant in the detergent composition used in accordance with the invention is advantageously from 1 to 10%, preferably from 2 to 5%, more preferably from approximately 3% by weight relative to the total weight of the composition.
  • the detergent composition used in accordance with the invention may further comprise an acid or a buffer system for adjusting the pH.
  • an organic acid is added, chosen from C 2 -C 6 mono-, di- and tricarboxylic acids, especially chosen from citric acid, tartaric acid, malic acid, lactic acid, glutaric acid, gluconic acid glycolic acid, succinic acid and adipic acid.
  • Citric acid is particularly preferred. It has the advantage of serving at the same time as a complexing agent such as tartaric acid and gluconic acid.
  • the composition will not contain an antimicrobial agent, in particular no antimicrobial amine, and will therefore have no claim for antimicrobial activity at the dose of use. This is to be distinguished from a bacteriostatic effect which on the other hand can be sought.
  • the detergent composition used in accordance with the invention may also comprise a preservative.
  • the preservative can be chosen from the preservatives usually used, such as for example 5-chloro-5-methyl-4-isothiazoline-3-one, 2-methyl-4-isothiazolin3-one, p- acid hydroxybenzoic acid and its methyl esters, 5-bromo-5-nitro-1,3-dioxane and salicylic acid, benzyl alcohol and sodium benzoate.
  • the detergent composition used in accordance with the invention may also comprise a hydrotropic agent.
  • This hydrotropic agent can for example be chosen from xylenesulfonates, toluenesulfonates, cumenesulfonates, urea, methylacetamide, polyethylene glycol and polypropylene glycol.
  • the concentrated detergent composition used in accordance with the invention may also comprise other adjuvants such as, for example, dispersing agents and / or anti-foaming agents.
  • the dispersing agents can for example be acids of homo-, co- or terpolymers based on acrylic acid or alkali metal salts thereof (polyacrylates).
  • the detergent composition is used in a washer-disinfector (LD) such as a washer-disinfector of instruments (LDI) or a washer-disinfector of endoscope (LDE).
  • LD washer-disinfector
  • LDE washer-disinfector of endoscope
  • the term "washer-disinfectorā€ should be understood as defined in standard ISO 15883-1: 2006, namely a machine intended for cleaning and disinfecting medical devices and all other articles used in the medical, dental, pharmaceutical and veterinary.
  • surgical and / or medical instruments as used in the present application is to be understood broadly as designating medical devices and all other articles used in the medical, dental, pharmaceutical and veterinary environments requiring cleaning. with aqueous detergents before reuse.
  • this cleaning is advantageously carried out at a temperature of 20 to 60 Ā° C., preferably from 45 to 55 Ā° C., more preferably from 50 to 55 Ā° C.
  • the cleaning time is advantageously between 20 s and 10 min, preferably between 30 s and 5 min.
  • the present invention also relates to the concentrated aqueous detergent composition used in the use according to the invention as described above.
  • This composition is to be diluted with water, preferably softened, demineralized or osmosis, before use.
  • the dilution is generally from 0.03% to 1% (v / v), preferably from 0.1% to 0.6% (v / v), more preferably from 0.2 to 0.4% (v / v) .
  • the pH of the ready-to-use diluted composition is advantageously from 8 to 11, preferably from 8.5 to 9.5, more preferably from 8.8 to 9.2 and even more preferably from approximately 9.
  • softened water is used (degree of hardness of approximately 5 Ā° f).
  • compositions C1, C2 and C3 give completely satisfactory results under the test conditions. The best results are however obtained with composition C1. With this composition, we do not detect any trace on the three tests used ( Figure 1 ).
  • composition C1 was compared with that of AnisoymeĀ® DLM Maxi (Laboratoires Anios, Hellemmes, France), a trienzymatic detergent containing a protease, a lipase, an amylase and the chelating agent EDTA.
  • the on-board test used was the TOSI AMCOR (reference 35002577).
  • composition according to the invention allows more effective cleaning at low temperatures and dosages. This is all the more surprising since the chelating activity of EDTA is at the base superior to that of MGDA which would allow waiting for a superior cleaning efficiency for AniosymeĀ® DLM Maxi.
  • composition C1 The respective stabilities of subtilisin, lipase and amylase in composition C1 were evaluated by the following tests.
  • subtilisin contained in the detergent is followed by the technique of electrophoresis on polyacrylamide gel, the substrate used is a solution of human serum albumin at 0.3% (soiling representative of an application in health care establishment ).
  • the Figure 2 shows four tracks of electrophoresis: track 1 corresponds to the control (human albumin serum (0.3%) not degraded), tracks 2, 3 and 4 to composition C1 after manufacture, 3 weeks of storage in a hermetically closed container at 30 Ā° C and 7 weeks of storage in a tightly closed container at 30 Ā° C respectively. It is noted that the enzymatic activity of subtilisin does not degrade for at least 7 weeks.
  • the activity of the lipase was followed by the technique of thin layer chromatography (TLC), the substrate used is a triglyceride and the eluent a mixture of 50 ml of heptane, 20 ml of diethyl ether, 0 , 5 mL of acetic acid and 1.5 mL of ethanol.
  • TLC thin layer chromatography
  • Lipase degrading triglycerides the absence of triglycerides, and the presence of diglycerides and monglycerides highlights the enzymatic activity of lipase.
  • the Figure 3 shows six tracks of CCM: tracks 1, 2, 3 correspond to the controls (1: triglycerides, 2: diglycerides, 3: monoglycerides), tracks 4, 5 and 6 with composition C1 after manufacture, after 3 weeks of storage in a tightly closed container at 30 Ā° C and after 7 weeks of storage in a tightly closed container at 30 Ā° C respectively. It is noted that the enzymatic activity of the lipase does not degrade for at least 7 weeks.
  • the activity of the amylase was followed by the technique of thin layer chromatography (TLC), the substrate used is glycogen and the eluent a mixture of 70 ml of ethanol, 1 ml of acetic acid and 29 mL of demineralized water.
  • TLC thin layer chromatography
  • Amylase degrading glycogen, the absence of glycogen and the presence of glucose demonstrate the enzymatic activity of amylase.
  • the Figure 4 shows five tracks of CCM: tracks 1 and 2 correspond to the controls (1: glycogen, 2: glucose), tracks 3, 4 and 5 to composition C1 after manufacture, after 3 weeks of storage in a container hermetically closed at 30 Ā° C and after 7 weeks of storage in a tightly closed container at 30 Ā° C respectively. It is noted that the enzymatic activity of amylase does not degrade for at least 7 weeks.
  • composition C1 The influence of the presence of the three enzymes subtilisin, lipase and amylase in the detergent composition was evaluated by comparing composition C1 with compositions without enzymes (C4), with subtilisin (C5) and with lipase and amylase (C6).
  • the degreasing cleaning power of the various compositions was evaluated with respect to English soiling according to ISO standard 15883 which was applied with a brush on stainless steel blades (one blade per composition tested) and left to dry for one hour at ambient temperature. Then each blade was soaked with stirring (three-dimensional agitator, 50 rpm) for 15 min at room temperature in one of the four detergent compositions diluted to 0.3% (v / v) in softened water (5 Ā° f).
  • composition C1 The slides treated with compositions C4, C5 and C6 indeed showed significant residues of English soiling visible to the naked eye.
  • the determination of residual proteins by the MicroBCA technique confirms these observations.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Detergent Compositions (AREA)

Description

La prƩsente invention concerne l'utilisation de compositions dƩtergentes enzymatiques pour le nettoyage automatique d'instruments et/ou appareils chirurgicaux et/ou mƩdicaux.The present invention relates to the use of enzymatic detergent compositions for the automatic cleaning of surgical and / or medical instruments and / or apparatus.

En milieu hospitalier, les instruments chirurgicaux sont en gĆ©nĆ©ral soumis Ć  un nettoyage automatique en laveur dĆ©sinfecteur d'instruments (LDI) en utilisant des dĆ©tergents fortement alcalins suivi d'une dĆ©sinfection thermique ou chimique. Ces dĆ©tergents ont gĆ©nĆ©ralement un pH supĆ©rieur Ć  12 ce qui les rends trĆØs corrosifs.In hospitals, surgical instruments are generally subjected to automatic cleaning in a washer-disinfector of instruments (LDI) using strongly alkaline detergents followed by thermal or chemical disinfection. These detergents generally have a pH higher than 12 which makes them very corrosive.

Pour Ć©viter les dommages causĆ©s par ces dĆ©tergents alcalins, des dĆ©tergents enzymatiques ont Ć©tĆ© proposĆ©s. On connaĆ®t par exemple le MEDICLEANĀ® forte de Dr. Weigert qui fait d'ailleurs l'objet du brevet europĆ©en EP 1 327 674 B1 . Ce dĆ©tergent contient de la triĆ©thanolamine, de l'acide nitrilotriacĆ©tique (NTA) comme agent chĆ©latant, des phosphates et une protĆ©ase. La prĆ©sence simultanĆ©e d'une alcanolamine et d'une enzyme dans une mĆŖme composition pose des problĆØmes de stabilitĆ© pour l'enzyme, notamment lorsque la composition est trĆØs concentrĆ©e.To avoid the damage caused by these alkaline detergents, enzymatic detergents have been proposed. We know for example the MEDICLEANĀ® forte from Dr. Weigert which is also the subject of the European patent EP 1 327 674 B1 . This detergent contains triethanolamine, nitrilotriacetic acid (NTA) as a chelating agent, phosphates and a protease. The simultaneous presence of an alkanolamine and an enzyme in the same composition poses stability problems for the enzyme, especially when the composition is very concentrated.

C'est pourquoi Dr. Weigert a dĆ©veloppĆ© le neodisherĀ® SYSTEM ALPHA qui est composĆ© de deux composantes trĆØs concentrĆ©s distinctes, Ć  savoir une composante enzymatique, le neodisherĀ® SystemAct, et une composante alcaline, le neodisherĀ® SystemClean. La composante enzymatique contient une subtilisine tandis que la composante alcaline contient de la triĆ©thanolamine et de l'acide mĆ©thylglycine diacĆ©tique (MGDA). Ce systĆØme fait d'ailleurs l'objet de la demande de brevet internationale WO2015/043777 .This is why Dr. Weigert has developed the neodisherĀ® SYSTEM ALPHA which is composed of two distinct highly concentrated components, namely an enzymatic component, the neodisherĀ® SystemAct, and an alkaline component, the neodisherĀ® SystemClean. The enzyme component contains a subtilisin while the alkaline component contains triethanolamine and methylglycine diacetic acid (MGDA). This system is also the subject of the international patent application WO2015 / 043777 .

MĆŖme si ce systĆØme permet de rĆ©soudre les problĆØmes liĆ©s Ć  l'instabilitĆ© de l'enzyme en prĆ©sence de fortes concentrations d'agents alcalins comme les alcanolamines, il prĆ©sente un dĆ©savantage majeur en ce qu'il nĆ©cessite un Ć©quipement spĆ©cifique pour pouvoir alimenter le laveur dĆ©sinfecteur d'instruments avec les deux composantes simultanĆ©ment. Les laveurs dĆ©sinfecteurs d'instruments ne possĆØdent en effet qu'une alimentation de composition dĆ©tergente.Even if this system makes it possible to solve the problems linked to the instability of the enzyme in the presence of high concentrations of alkaline agents such as alkanolamines, it has a major disadvantage in that it requires specific equipment to be able to feed the instrument washer-disinfector with the two components simultaneously. Instrument washer-disinfectors only have a supply of detergent composition.

Le brevet US 7,723,281 dĆ©crit une composition dĆ©tergente comprenant un systĆØme enzymatique stabilisĆ©. Ce systĆØme enzymatique comprend au moins une enzyme mais peut en comprendre plusieurs, tel qu'une protĆ©ase, une amylase, une lipase, une gluconase, une cellulase, une peroxidase ou un mĆ©lange de celles-ci, ainsi qu'un agent chĆ©latant. Selon la description, l'effet stabilisant est obtenu grĆ¢ce Ć  l'incorporation d'une amine, notamment anti-microbienne, et d'un acide dans un ratio molaire spĆ©cifique.The patent US 7,723,281 describes a detergent composition comprising a stabilized enzyme system. This enzymatic system comprises at least one enzyme but may include several, such as a protease, an amylase, a lipase, a gluconase, a cellulase, a peroxidase or a mixture thereof, as well as a chelating agent. According to the description, the stabilizing effect is obtained by incorporating an amine, in particular an antimicrobial, and an acid in a specific molar ratio.

Il existe donc toujours un besoin d'un moyen pour nettoyer efficacement les instruments chirurgicaux et mĆ©dicaux en machine sans prĆ©senter les problĆØmes de stabilitĆ© des solutions proposĆ©es dans l'Ć©tat de la technique et sans nĆ©cessiter un appareillage spĆ©cifique pour pouvoir alimenter les machines utilisĆ©es pour le nettoyage.There is therefore always a need for a means for effectively cleaning surgical and medical instruments in a machine without presenting the problems of stability of the solutions proposed in the prior art and without requiring specific apparatus in order to be able to supply the machines used for the cleaning.

Il est du mĆ©rite de la Demanderesse d'avoir trouvĆ© au fruit de nombreuses recherches que ces inconvĆ©nients pouvaient ĆŖtre palliĆ©s en utilisant une composition dĆ©tergente concentrĆ©e qui repose sur la combinaison de trois enzymes et d'un agent chĆ©latant puissant et qui ne contient pas d'alcanolamine.It is to the credit of the Applicant to have found in the fruit of numerous researches that these drawbacks could be overcome by using a concentrated detergent composition which is based on the combination of three enzymes and a powerful chelating agent and which does not contain any alkanolamine.

L'invention concerne donc l'utilisation d'une composition dƩtergente aqueuse concentrƩe pour le nettoyage d'instruments chirurgicaux et/ou mƩdicaux en laveur dƩsinfecteur, ladite composition dƩtergente aqueuse concentrƩe comprenant :

  • une subtilisine,
  • une lipase,
  • une amylase,
  • un agent chĆ©latant biodĆ©gradable choisi parmi l'acide mĆ©thylglycine diacĆ©tique (MGDA) et un iminodisuccinate (IDS) et
  • de l'eau,
ladite composition dƩtergente concentrƩe Ʃtant exempte d'alcanolamine.The invention therefore relates to the use of a concentrated aqueous detergent composition for cleaning surgical and / or medical instruments in a washer-disinfector, said concentrated aqueous detergent composition comprising:
  • a subtilisin,
  • lipase,
  • an amylase,
  • a biodegradable chelating agent chosen from acid diacetic methylglycine (MGDA) and an iminodisuccinate (IDS) and
  • some water,
said concentrated detergent composition being free of alkanolamine.

De faƧon tout Ć  fait surprenante, cette combinaison spĆ©cifique d'une subtilisine, d'une lipase et d'une amylase avec du MGDA ou de l'IDS permet de s'affranchir de la nĆ©cessitĆ© de l'ajout d'alcanolamine tout en maintenant un nettoyage efficace d'instruments chirurgicaux et/ou mĆ©dicaux souillĆ©s en laveur dĆ©sinfecteur. Ainsi, la composition dĆ©tergente aqueuse concentrĆ©e de l'invention ne prĆ©sente pas les problĆØmes de stabilitĆ© enzymatique rencontrĆ©s dans les compositions enzymatiques de l'art antĆ©rieur contenant des alcanolamines.Surprisingly, this specific combination of a subtilisin, a lipase and an amylase with MGDA or IDS eliminates the need for adding alkanolamine while maintaining effective cleaning of soiled surgical and / or medical instruments in a washer-disinfector. Thus, the concentrated aqueous detergent composition of the invention does not present the problems of enzymatic stability encountered in the enzymatic compositions of the prior art containing alkanolamines.

De plus, Ć©tant donnĆ© que les principaux composants des tissus biologiques qui constituent des souillures majeures des instruments chirurgicaux et mĆ©dicaux sont protĆ©ines, lipides (triglycĆ©rides) et polymĆØres glucidiques (glycogĆØne), le cocktail tri-enzymatique de la composition dĆ©tergente aqueuse concentrĆ©e de l'invention hydrolysera simultanĆ©ment les trois cibles et donc en facilitera la dĆ©tergence.In addition, since the main components of biological tissues that constitute major stains in surgical and medical instruments are proteins, lipids (triglycerides) and carbohydrate polymers (glycogen), the tri-enzymatic cocktail of the concentrated aqueous detergent composition of the invention will simultaneously hydrolyze the three targets and thus facilitate detergency.

De plus, l'absence d'alcanolamine permet de formuler la composition dĆ©tergente utilisĆ©e conformĆ©ment Ć  l'invention de faƧon trĆØs concentrĆ©e. Ainsi, la teneur en eau de la composition dĆ©tergente aqueuse concentrĆ©e peut ĆŖtre rĆ©duite jusqu'Ć  25 % en poids par rapport au poids total de composition sans pour autant devoir ajouter de quantitĆ©s importantes de tiers-solvant, impacter la stabilitĆ© des enzymes et nuire Ć  l'efficacitĆ© de nettoyage.In addition, the absence of alkanolamine makes it possible to formulate the detergent composition used in accordance with the invention in a very concentrated manner. Thus, the water content of the concentrated aqueous detergent composition can be reduced up to 25% by weight relative to the total weight of the composition without having to add significant amounts of third-solvent, impact the stability of the enzymes and harm cleaning efficiency.

La composition utilisƩe conformƩment Ơ l'invention a avantageusement une teneur en subtilisine de 0,5 Ơ 15% en poids par rapport au poids total de la composition, de prƩfƩrence de 1 Ơ 10% en poids par rapport au poids total de la composition, de prƩfƩrence de 1 Ơ 5% en poids par rapport au poids total de la composition, plus prƩfƩrentiellement d'environ 3% en poids par rapport au poids total de la composition. La teneur en lipase est avantageusement de 0,05 Ơ 2% en poids par rapport au poids total de la composition, de prƩfƩrence de 0,5 Ơ 1,5% en poids par rapport au poids total de la composition, plus prƩfƩrentiellement d'environ 1% en poids par rapport au poids total de la composition. La teneur en amylase est avantageusement de 0,05 Ơ 2% en poids par rapport au poids total de la composition, de prƩfƩrence de 0,5 Ơ 1,5% en poids par rapport au poids total de la composition, plus prƩfƩrentiellement d'environ 1% en poids par rapport au poids total de la composition.The composition used in accordance with the invention advantageously has a subtilisin content of 0.5 to 15% by weight relative to the total weight of the composition, preferably from 1 to 10% by weight relative to the total weight of the composition, preferably from 1 to 5% by weight relative to the total weight of the composition, more preferably around 3% by weight. relative to the total weight of the composition. The lipase content is advantageously from 0.05 to 2% by weight relative to the total weight of the composition, preferably from 0.5 to 1.5% by weight relative to the total weight of the composition, more preferably from about 1% by weight relative to the total weight of the composition. The amylase content is advantageously from 0.05 to 2% by weight relative to the total weight of the composition, preferably from 0.5 to 1.5% by weight relative to the total weight of the composition, more preferably from about 1% by weight relative to the total weight of the composition.

L'agent chĆ©latant biodĆ©gradable est choisi parmi l'acide mĆ©thylglycine diacĆ©tique (MGDA) et un iminodisuccinate (IDS), notamment l'iminodisuccinate tĆ©trasodique. De prĆ©fĆ©rence, l'agent chĆ©latant biodĆ©gradable est de l'acide mĆ©thylglycine diacĆ©tique (MGDA). Sans vouloir ĆŖtre liĆ© par une quelconque thĆ©orie, les inventeurs pensent que l'agent chĆ©latant mis en œuvre dans la prĆ©sente invention ne sert pas uniquement Ć  l'adoucissement de l'eau mais aussi Ć  complexer de maniĆØre particuliĆØrement efficace des ions mĆ©talliques bi- et trivalents, notamment Ca2+, Fe3+, Fe2+ et Cu2+, contenus dans les rĆ©sidus protĆ©iques retrouvĆ©s typiquement sur les instruments chirurgicaux et/ou mĆ©dicaux. Il semblerait que ces agents chĆ©latants sĆ©questrent ces ions mĆ©talliques ce qui dĆ©stabilise la structure tertiaire des protĆ©ines et les rends plus facilement hydrolysables.The biodegradable chelating agent is chosen from methylglycine diacetic acid (MGDA) and an iminodisuccinate (IDS), in particular the tetrasodium iminodisuccinate. Preferably, the biodegradable chelating agent is methylglycine diacetic acid (MGDA). Without wishing to be bound by any theory, the inventors believe that the chelating agent used in the present invention is not only used for softening water but also for complexing in a particularly effective way metal ions bi- and trivalent, in particular Ca 2+ , Fe 3+ , Fe 2+ and Cu 2+ , contained in the protein residues typically found on surgical and / or medical instruments. These chelating agents seem to sequester these metal ions, which destabilizes the tertiary structure of proteins and makes them more easily hydrolyzable.

La composition utilisƩe conformƩment Ơ l'invention a avantageusement une teneur en agent chƩlatant biodƩgradable de 10 Ơ 50% en poids par rapport au poids total de la composition, de prƩfƩrence de 20 Ơ 40% en poids par rapport au poids total de la composition, plus prƩfƩrentiellement de 25 Ơ 35% en poids par rapport au poids total de la composition, plus prƩfƩrentiellement encore d'environ 30% en poids par rapport au poids total de la composition.The composition used in accordance with the invention advantageously has a content of biodegradable chelating agent of 10 to 50% by weight relative to the total weight of the composition, preferably from 20 to 40% by weight relative to the total weight of the composition, more preferably from 25 to 35% by weight relative to the total weight of the composition, more preferably still around 30% by weight relative to the total weight of the composition.

La composition dĆ©tergente aqueuse concentrĆ©e est avantageusement exempte de tout agent chĆ©latant non bio-dĆ©gradable, notamment d'acide Ć©thylĆØne-diamine-tĆ©traacĆ©tique (EDTA), acide diĆ©thylĆØne-triamine-pentaacĆ©tique (DTPA), phosphates et polyphosphates. Avantageusement, la composition dĆ©tergente aqueuse concentrĆ©e est Ć©galement exempte de tout agent chĆ©latant classĆ© rĆ©protoxique tel que l'acide nitrilotriacĆ©tique et son sel de sodium (NTA).The concentrated aqueous detergent composition is advantageously free from any non-biodegradable chelating agent, in particular ethylene-diamine-tetraacetic acid (EDTA), diethylene-triamine-pentaacetic acid. (DTPA), phosphates and polyphosphates. Advantageously, the concentrated aqueous detergent composition is also free from any chelating agent classified as reprotoxic such as nitrilotriacetic acid and its sodium salt (NTA).

Dans un mode de rƩalisation, la composition dƩtergente aqueuse concentrƩe est Ʃgalement exempte d'hydroxydes alcalins et alcalinoterreux.In one embodiment, the concentrated aqueous detergent composition is also free from alkali and alkaline earth hydroxides.

La teneur en eau de la composition dĆ©tergente concentrĆ©e utilisĆ©e conformĆ©ment Ć  l'invention est avantageusement de 10 Ć  50 % en poids par rapport au poids total de la composition, de prĆ©fĆ©rence de 15 Ć  45 % en poids par rapport au poids total de la composition, plus prĆ©fĆ©rentiellement de 20 Ć  40 % en poids par rapport au poids total de la composition et plus prĆ©fĆ©rentiellement encore de 25 Ć  40% en poids par rapport au poids total de la composition. En plus de l'eau, la composition dĆ©tergente concentrĆ©e peut Ć©galement contenir un tiers-solvant tel un polyol. Des exemples de polyols appropriĆ©s comprennent notamment les alkylĆØnes glycols tels que l'Ć©thylĆØne glycol, le propylĆØne glycol et la glycĆ©rine (1,2,3-propanetriol). De prĆ©fĆ©rence, le tiers-solvant est la glycĆ©rine. La glycĆ©rine a l'avantage de ne pas servir uniquement de tiers-solvant mais de stabiliser Ć©galement les enzymes.The water content of the concentrated detergent composition used in accordance with the invention is advantageously from 10 to 50% by weight relative to the total weight of the composition, preferably from 15 to 45% by weight relative to the total weight of the composition , more preferably from 20 to 40% by weight relative to the total weight of the composition and more preferably still from 25 to 40% by weight relative to the total weight of the composition. In addition to water, the concentrated detergent composition may also contain a third solvent such as a polyol. Examples of suitable polyols include alkylene glycols such as ethylene glycol, propylene glycol and glycerin (1,2,3-propanetriol). Preferably, the third solvent is glycerin. Glycerin has the advantage of not only serving as a third solvent but also of stabilizing the enzymes.

La teneur en tiers-solvant est avantageusement de 5 Ơ 50 % en poids par rapport au poids total de la composition, de prƩfƩrence de 10 Ơ 40 % en poids par rapport au poids total de la composition, plus prƩfƩrentiellement de 13 Ơ 25 % en poids par rapport au poids total de la composition.The content of third-solvent is advantageously from 5 to 50% by weight relative to the total weight of the composition, preferably from 10 to 40% by weight relative to the total weight of the composition, more preferably from 13 to 25% by weight. weight relative to the total weight of the composition.

La composition dĆ©tergente concentrĆ©e utilisĆ©e conformĆ©ment Ć  l'invention peut en outre comprendre un ou plusieurs tensioactifs non ioniques. Le ou les agents tensioactifs non ioniques peuvent notamment ĆŖtre choisis parmi les tensioactifs non ioniques alcoxylĆ©s et les alkylpolyglucosides. Les tensioactifs non ioniques alcoxylĆ©s sont avantageusement choisis parmi les tensioactifs non ioniques alcoxylĆ©s, notamment parmi les alcools gras alcoxylĆ©s, notamment Ć©thoxylĆ©s et/ou propoxylĆ©s, et les copolymĆØres blocs EO-PO. Dans un mode de rĆ©alisation prĆ©fĆ©rĆ©, le ou les agents tensioactifs non ioniques sont choisis parmi les alkylpolyglucosides, de prĆ©fĆ©rence il s'agit d'un alkylpolyglucoside en C7. Cet alkylpolyglucoside apporte en effet le triple avantage de jouer un rĆ“le de stabilisant, d'apporter un effet mouillant favorable Ć  la dĆ©tergence et un caractĆØre non-moussant compatible avec une application en laveur dĆ©sinfecteur.The concentrated detergent composition used in accordance with the invention may also comprise one or more nonionic surfactants. The nonionic surfactant (s) may in particular be chosen from alkoxylated nonionic surfactants and alkylpolyglucosides. The alkoxylated nonionic surfactants are advantageously chosen from alkoxylated nonionic surfactants, in particular from alkoxylated fatty alcohols, in particular ethoxylated and / or propoxylated, and EO-PO block copolymers. In a preferred embodiment, the nonionic surfactant (s) are chosen from alkylpolyglucosides, preferably it is a C7 alkylpolyglucoside. This alkylpolyglucoside indeed brings the triple advantage of playing a stabilizing role, of bringing a wetting effect favorable to detergency and a non-foaming character compatible with an application in washer-disinfector.

La teneur en tensioactif non ionique dans la composition dƩtergente utilisƩe conformƩment Ơ l'invention est avantageusement de 1 Ơ 10 %, de prƩfƩrence de 2 Ơ 5 %, plus prƩfƩrentiellement d'environ 3 % en poids par rapport au poids total de la composition.The content of nonionic surfactant in the detergent composition used in accordance with the invention is advantageously from 1 to 10%, preferably from 2 to 5%, more preferably from approximately 3% by weight relative to the total weight of the composition.

La composition dĆ©tergente utilisĆ©e conformĆ©ment Ć  l'invention peut en outre comprendre un acide ou un systĆØme de tampon pour ajuster le pH. De prĆ©fĆ©rence, on ajoute un acide organique, choisi parmi les acides en C2-C6 mono-, di- et tricarboxyliques, notamment choisi parmi l'acide citrique, l'acide tartrique, l'acide malique, l'acide lactique, l'acide glutarique, l'acide gluconique l'acide glycolique, l'acide succinique et l'acide adipique. L'acide citrique est particuliĆØrement prĆ©fĆ©rĆ©. Elle prĆ©sente l'avantage de servir en mĆŖme temps comme agent complexant comme Ć©galement l'acide tartrique et l'acide gluconique.The detergent composition used in accordance with the invention may further comprise an acid or a buffer system for adjusting the pH. Preferably, an organic acid is added, chosen from C 2 -C 6 mono-, di- and tricarboxylic acids, especially chosen from citric acid, tartaric acid, malic acid, lactic acid, glutaric acid, gluconic acid glycolic acid, succinic acid and adipic acid. Citric acid is particularly preferred. It has the advantage of serving at the same time as a complexing agent such as tartaric acid and gluconic acid.

Avantageusement, la composition ne contiendra pas d'agent antimicrobien, notamment pas d'aminĆ© antimicrobienne, et n'aura donc aucune revendication d'activitĆ© antimicrobienne Ć  la dose d'emploi. Celle-ci est Ć  distinguer d'un effet bactĆ©riostatique qui par contre pourra ĆŖtre recherchĆ©. A cet effet, la composition dĆ©tergente utilisĆ©e conformĆ©ment Ć  l'invention peut Ć©galement comprendre un agent conservateur. L'agent conservateur peut ĆŖtre choisi parmi les agents conservateurs habituellement utilisĆ©s, comme par exemple le 5-chloro-5-mĆ©thyl-4-isothiazoline-3-one, le 2-mĆ©thyl-4-isothiazolin3-one, l'acide p-hydroxybenzoĆÆque et ses esters de mĆ©thyl, le 5-bromo-5-nitro-1,3-dioxane et l'acide salicylique, l'alcool benzylique et le benzoate de sodium. Ces agents conservateurs permettent d'Ć©viter une contamination microbienne et fongique en apportant un effet bactĆ©riostatique et fongistatique.Advantageously, the composition will not contain an antimicrobial agent, in particular no antimicrobial amine, and will therefore have no claim for antimicrobial activity at the dose of use. This is to be distinguished from a bacteriostatic effect which on the other hand can be sought. To this end, the detergent composition used in accordance with the invention may also comprise a preservative. The preservative can be chosen from the preservatives usually used, such as for example 5-chloro-5-methyl-4-isothiazoline-3-one, 2-methyl-4-isothiazolin3-one, p- acid hydroxybenzoic acid and its methyl esters, 5-bromo-5-nitro-1,3-dioxane and salicylic acid, benzyl alcohol and sodium benzoate. These preservatives prevent microbial and fungal contamination by bringing a bacteriostatic and fungistatic effect.

La composition dĆ©tergente utilisĆ©e conformĆ©ment Ć  l'invention peut Ć©galement comprendre un agent hydrotrope. Cet agent hydrotrope peut par exemple ĆŖtre choisi parmi les xylĆØnesulfonates, les toluĆØnesulfonates, les cumĆØnes sulfonates, l'urĆ©e, le mĆ©thylacĆ©tamide, du polyĆ©thylĆØneglycol et du polypropylĆØneglycol.The detergent composition used in accordance with the invention may also comprise a hydrotropic agent. This hydrotropic agent can for example be chosen from xylenesulfonates, toluenesulfonates, cumenesulfonates, urea, methylacetamide, polyethylene glycol and polypropylene glycol.

La composition dĆ©tergente concentrĆ©e utilisĆ©e conformĆ©ment Ć  l'invention peut en outre comprendre d'autres adjuvants tels que par exemple des agents dispersants et/ou des agents anti-mousse. Les agents dispersants peuvent par exemple ĆŖtre des acides des homo-, co- ou terpolymĆØres Ć  base d'acide acrylique ou des sels de mĆ©taux alcalins de ceux-ci (polyacrylates).The concentrated detergent composition used in accordance with the invention may also comprise other adjuvants such as, for example, dispersing agents and / or anti-foaming agents. The dispersing agents can for example be acids of homo-, co- or terpolymers based on acrylic acid or alkali metal salts thereof (polyacrylates).

Dans l'utilisation selon l'invention, la composition dĆ©tergente est mise en œuvre dans un laveur dĆ©sinfecteur (LD) tel qu'un laveur dĆ©sinfecteur d'instruments (LDI) ou un laveur dĆ©sinfecteur d'endoscope (LDE). Le terme Ā« laveur dĆ©sinfecteur Ā» est Ć  comprendre tel qu'il est dĆ©fini dans la norme ISO 15883-1 :2006, Ć  savoir une machine destinĆ©e Ć  nettoyer et dĆ©sinfecter des dispositifs mĆ©dicaux et tous les autres articles utilisĆ©s dans les milieux mĆ©dical, dentaire, pharmaceutique et vĆ©tĆ©rinaire. Aussi, le terme Ā« instruments chirurgicaux et/ou mĆ©dicaux Ā» tels qu'utilisĆ© dans la prĆ©sente demande est Ć  comprendre de faƧon large comme dĆ©signant les dispositifs mĆ©dicaux et tous les autres articles utilisĆ©s dans les milieux mĆ©dical, dentaire, pharmaceutique et vĆ©tĆ©rinaire nĆ©cessitant un nettoyage avec des dĆ©tergents aqueux avant rĆ©utilisation.In the use according to the invention, the detergent composition is used in a washer-disinfector (LD) such as a washer-disinfector of instruments (LDI) or a washer-disinfector of endoscope (LDE). The term "washer-disinfector" should be understood as defined in standard ISO 15883-1: 2006, namely a machine intended for cleaning and disinfecting medical devices and all other articles used in the medical, dental, pharmaceutical and veterinary. Also, the term "surgical and / or medical instruments" as used in the present application is to be understood broadly as designating medical devices and all other articles used in the medical, dental, pharmaceutical and veterinary environments requiring cleaning. with aqueous detergents before reuse.

Dans la prĆ©sente invention, ce nettoyage est avantageusement mise en œuvre Ć  une tempĆ©rature de 20 Ć  60 Ā°C, de prĆ©fĆ©rence de 45 Ć  55 Ā°C, plus prĆ©fĆ©rentiellement de 50 Ć  55 Ā°C. La durĆ©e de nettoyage est avantageusement comprise entre 20 s et 10 min, de prĆ©fĆ©rence entre 30 s et 5 min.In the present invention, this cleaning is advantageously carried out at a temperature of 20 to 60 Ā° C., preferably from 45 to 55 Ā° C., more preferably from 50 to 55 Ā° C. The cleaning time is advantageously between 20 s and 10 min, preferably between 30 s and 5 min.

La prĆ©sente invention porte Ć©galement sur la composition dĆ©tergente aqueuse concentrĆ©e mise en œuvre dans l'utilisation selon l'invention telle que dĆ©crite ci-dessus. Cette composition est Ć  diluer avec de l'eau, prĆ©fĆ©rentiellement adoucie, dĆ©minĆ©ralisĆ©e ou osmosĆ©e, avant emploi. La dilution est gĆ©nĆ©ralement de 0,03% Ć  1% (v/v), de prĆ©fĆ©rence de 0,1% Ć  0.6% (v/v), plus prĆ©fĆ©rentiellement de 0,2 Ć  0,4% (v/v). Le pH de la composition diluĆ©e prĆŖte Ć  l'emploi est avantageusement de 8 Ć  11, de prĆ©fĆ©rence de 8,5 Ć  9,5, plus prĆ©fĆ©rentiellement de 8,8 Ć  9,2 et plus prĆ©fĆ©rentiellement encore d'environ 9. Pour la dĆ©termination du pH de la composition diluĆ©e, de l'eau adoucie est utilisĆ©e (degrĆ© de duretĆ© d'environ 5Ā°f).The present invention also relates to the concentrated aqueous detergent composition used in the use according to the invention as described above. This composition is to be diluted with water, preferably softened, demineralized or osmosis, before use. The dilution is generally from 0.03% to 1% (v / v), preferably from 0.1% to 0.6% (v / v), more preferably from 0.2 to 0.4% (v / v) . The pH of the ready-to-use diluted composition is advantageously from 8 to 11, preferably from 8.5 to 9.5, more preferably from 8.8 to 9.2 and even more preferably from approximately 9. For the determination of the pH of the diluted composition, softened water is used (degree of hardness of approximately 5 Ā° f).

L'invention sera maintenant dƩcrite Ơ l'aide d'exemples non limitatifs de rƩalisation de l'invention.The invention will now be described with the aid of nonlimiting examples of embodiment of the invention.

FIGURESFIGURES

  • Figure 1 : Photos des tests de dĆ©tergence embarquĆ© pour les compositions C1, C2 et C3. Figure 1 : Photos of on-board detergency tests for compositions C1, C2 and C3.
  • Figure 2 : Evaluation de l'activitĆ© de la subtilisine par Ć©lectrophorĆØse sur gel. Figure 2 : Evaluation of the activity of subtilisin by gel electrophoresis.
  • Figure 3 : Evaluation de l'activitĆ© de la lipase par chromatographie sur couche mince. Figure 3 : Evaluation of the activity of lipase by thin layer chromatography.
  • Figure 4 : Evaluation de l'activitĆ© de l'amylase par chromatographie sur couche mince. Figure 4 : Evaluation of the activity of amylase by thin layer chromatography.
EXEMPLESEXAMPLES

Les trois compositions dĆ©tergentes concentrĆ©es suivantes (tableau 1) ont Ć©tĆ© Ć©valuĆ©es pour leur capacitĆ© Ć  nettoyer efficacement des rĆ©sidus typiquement retrouvĆ© sur des instruments chirurgicaux et mĆ©dicaux. Tableau 1 Composition (% en poids/poids total) C1 C2 C3 Eau dĆ©minĆ©ralisĆ©e 38,91 35,2 45,5 Acide citrique 2,5 2,5 2,5 GlycĆ©rine technique 20 20 20 Alcool gras Ć©thoxylĆ© 3 3 3 Chlorure de dioctyl dimĆ©thyl ammonium 0,5 0,5 0,5 MĆ©thylisothiazolinone et mĆ©thylchloroisothiazolinone 0,09 0,09 0,09 MGDA 30 - - IDS - 35 15 Polyacrylate - - 10 SavinaseĀ® Ultra 16 XL (subtilisine) 3 3 3 Lipolase 1 1 1 Amylase 1 1 1 pH (concentrĆ©, 20Ā°C) 9 9 9 pH (dilution Ć  0,5 % (v/v) dans de l'eau adoucie (5Ā°f, 20Ā°C) 8.9 8.5 8.2 The following three concentrated detergent compositions (Table 1) were evaluated for their capacity to effectively clean residues typically found on surgical and medical instruments. <b> Table 1 </b> Composition (% by weight / total weight) C1 C2 C3 Demineralized Water 38.91 35.2 45.5 Citric acid 2.5 2.5 2.5 Technical glycerin 20 20 20 Ethoxylated fatty alcohol 3 3 3 Dioctyl dimethyl ammonium chloride 0.5 0.5 0.5 Methylisothiazolinone and methylchloroisothiazolinone 0.09 0.09 0.09 MGDA 30 - - IDS - 35 15 Polyacrylate - - 10 SavinaseĀ® Ultra 16 XL (subtilisin) 3 3 3 Lipolase 1 1 1 Amylase 1 1 1 pH (concentrated, 20 Ā° C) 9 9 9 pH (dilution to 0.5% (v / v) in softened water (5 Ā° f, 20 Ā° C) 8.9 8.5 8.2

EXEMPLE 1: Essais de dƩtergence embarquƩs en laveur dƩsinfecteur MIELE G7836CDEXAMPLE 1: On-board detergency tests in a MIELE G7836CD washer-disinfector 1) DƩroulement du cycle1) Cycle sequence

  • Injection du dĆ©tergent Ć  35Ā°C, dilution de 0,3% (v/v) en eau adoucieInjection of detergent at 35 Ā° C, dilution of 0.3% (v / v) in softened water
  • Lavage avec de l'eau adoucie pendant 3mn Ć  55Ā°CWash with softened water for 3 minutes at 55 Ā° C
  • RinƧage avec de l'eau de rĆ©seau froideRinse with cold tap water
  • SĆ©chageDrying
2) Les diffƩrents tests embarquƩs utilisƩs2) The different on-board tests used

  • Simicon (SIMICON PET-K-10 de SIMICON GmbH, Munich, Allemagne)Simicon (SIMICON PET-K-10 from SIMICON GmbH, Munich, Germany)
  • Wash check H (Getinge, Sweden)Wash check H (Getinge, Sweden)
  • Load Check Browne (Steris, USA)Load Check Browne (Steris, USA)

Les diffƩrents tests ont ƩtƩ utilisƩs selon les modes d'emplois fournit par le fabricant respectif.The different tests were used according to the instructions for use provided by the respective manufacturer.

3) RĆ©sultats des essais3) Test results

Les essais de performance ont montrƩ que les trois compositions C1, C2 et C3 donnent des rƩsultats tout Ơ fait satisfaisants dans les conditions de tests. Les meilleurs rƩsultats sont toutefois obtenus avec la composition C1. Avec cette composition, on ne dƩtecte en effet aucune trace sur les trois tests utilisƩs (Figure 1).The performance tests have shown that the three compositions C1, C2 and C3 give completely satisfactory results under the test conditions. The best results are however obtained with composition C1. With this composition, we do not detect any trace on the three tests used ( Figure 1 ).

Les essais ont Ć©tĆ© rĆ©pĆ©tĆ©s Ć  une tempĆ©rature de nettoyage de 40Ā°C et une dilution des compositions Ć  0,5 % (v/v). Les rĆ©sultats obtenus sont comparables Ć  ceux obtenus Ć  40Ā°C et confirment donc l'efficacitĆ© des compositions selon l'invention.The tests were repeated at a cleaning temperature of 40 Ā° C and a dilution of the compositions to 0.5% (v / v). The results obtained are comparable to those obtained at 40 Ā° C and therefore confirm the effectiveness of the compositions according to the invention.

EXEMPLE 2 : Essais de dƩtergence comparatifs en laveur dƩsinfecteur MIELE PG 8528EXAMPLE 2: Comparative detergency tests in a MIELE PG 8528 washer-disinfector

La performance de la composition C1 a Ć©tĆ© comparĆ©e Ć  celle de l'Anisoyme Ā® DLM Maxi (Laboratoires Anios, Hellemmes, France), un dĆ©tergent trienzymatique contenant une protĆ©ase, une lipase, une amylase et l'agent chĆ©latant EDTA. Le test embarquĆ© utilisĆ© Ć©tait le TOSI AMCOR (rĆ©fĆ©rence 35002577).The performance of composition C1 was compared with that of AnisoymeĀ® DLM Maxi (Laboratoires Anios, Hellemmes, France), a trienzymatic detergent containing a protease, a lipase, an amylase and the chelating agent EDTA. The on-board test used was the TOSI AMCOR (reference 35002577).

Pour chaque essai, le cycle de traitement se dƩroule comme suit :

  • PrĆ©lavage : eau de rĆ©seau froide, 1 min,
  • Lavage : eau adoucie (5Ā°f), 5 min, tempĆ©rature et dosage selon tableau 2 ci-dessous,
  • RinƧage : eau de rĆ©seau froide, 1 min,
  • RinƧage final : eau osmosĆ©e Ć  90Ā°C, 1 min avec de l'Anios RDA Ć  0,05 % (v/v).
For each trial, the treatment cycle proceeds as follows:
  • Prewash: cold mains water, 1 min,
  • Washing: softened water (5 Ā° f), 5 min, temperature and dosage according to table 2 below,
  • Rinsing: cold mains water, 1 min,
  • Final rinse: osmosis water at 90 Ā° C, 1 min with 0.05% (v / v) Anios RDA.

Le tableau 2 ci-dessous rĆ©capitule les conditions d'essais et les rĆ©sultats. Tableau 2 DĆ©tergent : C1 C1 Aniosyme DLM Maxi Aniosyme DLM Maxi Dosage (% v/v) 0,2 0,1 0,2 0,1 TempĆ©rature de lavage 45Ā°C 50Ā°C 45Ā°C 50Ā°C RĆ©sulat aucune trace aucune trace traces de fibrine traces de fibrine Table 2 below summarizes the test conditions and results. <b> Table 2 </b> Detergent: C1 C1 Aniosyme DLM Maxi Aniosyme DLM Maxi Dosage (% v / v) 0.2 0.1 0.2 0.1 Wash temperature 45 Ā° C 50 Ā° C 45 Ā° C 50 Ā° C Result no trace no trace traces of fibrin traces of fibrin

Ces essais montrent que la composition selon l'invention permet un nettoyage plus efficace Ć  des tempĆ©ratures et dosage faibles. Ceci est d'autant plus surprenant que l'activitĆ© chĆ©latant de l'EDTA est Ć  la base supĆ©rieure Ć  celle du MGDA ce qui laisserait attendre une efficacitĆ© de nettoyage supĆ©rieure pour l'AniosymeĀ® DLM Maxi.These tests show that the composition according to the invention allows more effective cleaning at low temperatures and dosages. This is all the more surprising since the chelating activity of EDTA is at the base superior to that of MGDA which would allow waiting for a superior cleaning efficiency for AniosymeĀ® DLM Maxi.

EXEMPLE 3 : Evaluation de l'activitƩ des enzymes dans la composition C1EXAMPLE 3 Evaluation of the Activity of Enzymes in Composition C1

Les stabilitƩs respectives de la subtilisine, de la lipase et de l'amylase dans la composition C1 ont ƩtƩ ƩvaluƩes par les tests suivants.The respective stabilities of subtilisin, lipase and amylase in composition C1 were evaluated by the following tests.

1) ActivitƩ de la subtilisine1) Activity of subtilisin

L'activitĆ© de la subtilisine contenue dans le dĆ©tergent est suivie par la technique de l'Ć©lectrophorĆØse sur gel de polyacrylamide, le substrat utilisĆ© est une solution de sĆ©rum albumine humaine Ć  0,3% (salissure reprĆ©sentative d'une application en Ć©tablissement de santĆ©).The activity of the subtilisin contained in the detergent is followed by the technique of electrophoresis on polyacrylamide gel, the substrate used is a solution of human serum albumin at 0.3% (soiling representative of an application in health care establishment ).

AprĆØs migration, les protĆ©ines et peptides sont rĆ©vĆ©lĆ©s par exposition dans une solution colorante au bleu de Coomassie suivie d'une dĆ©coloration. Une rĆ©vĆ©lation au bleu de Coomassie permet de rĆ©vĆ©ler les produits de dĆ©gradation issus de l'hydrolyse du sĆ©rum albumine humaine.After migration, the proteins and peptides are revealed by exposure in a staining solution with Coomassie blue followed by discoloration. A revelation with Coomassie blue reveals the degradation products resulting from the hydrolysis of human albumin serum.

La Figure 2 montre quatre pistes d'Ć©lectrophorĆØse : la piste 1 correspond au tĆ©moin (sĆ©rum albumine humaine (0,3%) non dĆ©gradĆ©), les pistes 2, 3 et 4 Ć  la composition C1 aprĆØs fabrication, 3 semaines de stockage dans un contenant hermĆ©tiquement fermĆ© Ć  30Ā°C et 7 semaine de stockage dans un contenant hermĆ©tiquement fermĆ© Ć  30Ā°C respectivement. On constate que l'activitĆ© enzymatique de la subtilisine ne se dĆ©grade pas pendant au moins 7 semaines.The Figure 2 shows four tracks of electrophoresis: track 1 corresponds to the control (human albumin serum (0.3%) not degraded), tracks 2, 3 and 4 to composition C1 after manufacture, 3 weeks of storage in a hermetically closed container at 30 Ā° C and 7 weeks of storage in a tightly closed container at 30 Ā° C respectively. It is noted that the enzymatic activity of subtilisin does not degrade for at least 7 weeks.

2) ActivitƩ de la lipase2) Lipase activity

L'activitƩ de la lipase a ƩtƩ suivie par la technique de Chromatographie sur Couche Mince (CCM), le substrat utilisƩ est un triglycƩride et l'Ʃluant un mƩlange de 50 mL d'heptane, de 20 mL d'Ʃther diƩthylique, de 0,5 mL d'acide acƩtique et de 1.5mL d'Ʃthanol.The activity of the lipase was followed by the technique of thin layer chromatography (TLC), the substrate used is a triglyceride and the eluent a mixture of 50 ml of heptane, 20 ml of diethyl ether, 0 , 5 mL of acetic acid and 1.5 mL of ethanol.

La lipase dƩgradant les triglycƩrides, l'absence de triglycƩrides, et la prƩsence de diglycƩrides et de monglycƩrides met en Ʃvidence l'activitƩ enzymatique de la lipase.Lipase degrading triglycerides, the absence of triglycerides, and the presence of diglycerides and monglycerides highlights the enzymatic activity of lipase.

La Figure 3 montre six pistes de CCM : les pistes 1, 2, 3 correspondent aux tĆ©moins (1 : triglycĆ©rides, 2 : diglycĆ©rides, 3 : monoglycĆ©rides), les pistes 4, 5 et 6 Ć  la composition C1 aprĆØs fabrication, aprĆØs 3 semaines de stockage dans un contenant hermĆ©tiquement fermĆ© Ć  30Ā°C et aprĆØs 7 semaine de stockage dans un contenant hermĆ©tiquement fermĆ© Ć  30Ā°C respectivement. On constate que l'activitĆ© enzymatique de la lipase ne se dĆ©grade pas pendant au moins 7 semaines.The Figure 3 shows six tracks of CCM: tracks 1, 2, 3 correspond to the controls (1: triglycerides, 2: diglycerides, 3: monoglycerides), tracks 4, 5 and 6 with composition C1 after manufacture, after 3 weeks of storage in a tightly closed container at 30 Ā° C and after 7 weeks of storage in a tightly closed container at 30 Ā° C respectively. It is noted that the enzymatic activity of the lipase does not degrade for at least 7 weeks.

3) ActivitƩ de l'amylase3) Amylase activity

L'activitĆ© de l'amylase a Ć©tĆ© suivie par la technique de Chromatographie sur Couche Mince (CCM), le substrat utilisĆ© est du glycogĆØne et l'Ć©luant un mĆ©lange de 70 mL d'Ć©thanol, de 1 mL d'acide acĆ©tique et de 29 mL d'eau dĆ©minĆ©ralisĆ©e.The activity of the amylase was followed by the technique of thin layer chromatography (TLC), the substrate used is glycogen and the eluent a mixture of 70 ml of ethanol, 1 ml of acetic acid and 29 mL of demineralized water.

L'amylase dĆ©gradant le glycogĆØne, l'absence de glycogĆØne et la prĆ©sence de glucose mettent en Ć©vidence l'activitĆ© enzymatique de l'amylase.Amylase degrading glycogen, the absence of glycogen and the presence of glucose demonstrate the enzymatic activity of amylase.

La Figure 4 montre cinq pistes de CCM : les pistes 1 et 2 correspondent aux tĆ©moins (1 : glycogĆØne, 2 : glucose), les pistes 3, 4 et 5 Ć  la composition C1 aprĆØs fabrication, aprĆØs 3 semaines de stockage dans un contenant hermĆ©tiquement fermĆ© Ć  30Ā°C et aprĆØs 7 semaine de stockage dans un contenant hermĆ©tiquement fermĆ© Ć  30Ā°C respectivement. On constate que l'activitĆ© enzymatique de l'amylase ne se dĆ©grade pas pendant au moins 7 semaines.The Figure 4 shows five tracks of CCM: tracks 1 and 2 correspond to the controls (1: glycogen, 2: glucose), tracks 3, 4 and 5 to composition C1 after manufacture, after 3 weeks of storage in a container hermetically closed at 30 Ā° C and after 7 weeks of storage in a tightly closed container at 30 Ā° C respectively. It is noted that the enzymatic activity of amylase does not degrade for at least 7 weeks.

EXEMPLE 4 : Influence des enzymes sur le pouvoir nettoyant dƩgraissantEXAMPLE 4 Influence of enzymes on the degreasing cleaning power

L'influence de la prĆ©sence des trois enzymes subtilisine, lipase et amylase dans la composition dĆ©tergente a Ć©tĆ© Ć©valuĆ©e en comparant la composition C1 Ć  des compositions sans enzymes (C4), avec subtilisine (C5) et avec lipase et amylase (C6). Composition (% en poids/poids total) C1 C4 C5 C6 Eau dĆ©minĆ©ralisĆ©e 38,91 43,91 40,91 41,91 Acide citrique 2,5 2,5 2,5 2,5 GlycĆ©rine technique 20 20 20 20 Alcool gras Ć©thoxylĆ© 3 3 3 3 Chlorure de dioctyl dimĆ©thyl ammonium 0,5 0,5 0,5 0,5 MĆ©thylisothiazolinone et mĆ©thylchloroisothiazolinone 0,09 0,09 0,09 0,09 MGDA 30 30 30 30 SavinaseĀ® Ultra 16 XL (subtilisine) 3 - 3 - Lipolase 1 - - 1 Amylase 1 - - 1 The influence of the presence of the three enzymes subtilisin, lipase and amylase in the detergent composition was evaluated by comparing composition C1 with compositions without enzymes (C4), with subtilisin (C5) and with lipase and amylase (C6). Composition (% by weight / total weight) C1 C4 C5 C6 Demineralized Water 38.91 43.91 40.91 41.91 Citric acid 2.5 2.5 2.5 2.5 Technical glycerin 20 20 20 20 Ethoxylated fatty alcohol 3 3 3 3 Dioctyl dimethyl ammonium chloride 0.5 0.5 0.5 0.5 Methylisothiazolinone and methylchloroisothiazolinone 0.09 0.09 0.09 0.09 MGDA 30 30 30 30 SavinaseĀ® Ultra 16 XL (subtilisin) 3 - 3 - Lipolase 1 - - 1 Amylase 1 - - 1

Pour ces essais le pouvoir nettoyant dĆ©graissant des diffĆ©rentes compositions a Ć©tĆ© Ć©valuĆ© par rapport Ć  de la salissure anglaise selon la norme ISO 15883 qui a Ć©tĆ© appliquĆ©e au pinceau sur des lames en inox (une lame par composition testĆ©e) et laissĆ©e sĆ©cher pendant une heure Ć  tempĆ©rature ambiante. Ensuite chaque lame a Ć©tĆ© trempĆ©e sous agitation (agitateur tridimensionnel, 50 rpm) pendant 15 min Ć  tempĆ©rature ambiante dans l'une des quatre compositions dĆ©tergente diluĆ©e Ć  0,3 % (v/v) dans de l'eau adoucie (5Ā°f).For these tests, the degreasing cleaning power of the various compositions was evaluated with respect to English soiling according to ISO standard 15883 which was applied with a brush on stainless steel blades (one blade per composition tested) and left to dry for one hour at ambient temperature. Then each blade was soaked with stirring (three-dimensional agitator, 50 rpm) for 15 min at room temperature in one of the four detergent compositions diluted to 0.3% (v / v) in softened water (5 Ā° f).

Les meilleurs rĆ©sultats ont Ć©tĆ© obtenus pour la composition C1. Les lames traitĆ©es avec les compositions C4, C5 et C6 prĆ©sentaient en effet d'importants rĆ©sidus de salissure anglaise visible Ć  l'œil nu. Le dosage des protĆ©ines rĆ©siduelles par la technique MicroBCA (kit INTERCHIM UPTIMA MicroBC Assay, rĆ©fĆ©rence UP75860A) confirme ces observations.The best results have been obtained for composition C1. The slides treated with compositions C4, C5 and C6 indeed showed significant residues of English soiling visible to the naked eye. The determination of residual proteins by the MicroBCA technique (INTERCHIM UPTIMA MicroBC Assay kit, reference UP75860A) confirms these observations.

Claims (11)

  1. Concentrated aqueous detergent composition comprising:
    - a subtilisin,
    - a lipase,
    - an amylase,
    - a biodegradable chelating agent selected from methyl glycine diacetic acid and an iminodisuccinate, and
    - water,
    said concentrated detergent composition being free of alkanolamine.
  2. Detergent composition according to claim 1, characterized by the fact that it has a subtilisin content of between 0.5 and 15% by weight when compared to the total weight of the composition.
  3. Detergent composition according to claim 1 or 2, characterized by the fact that it has a lipase content of between 0.05 and 2% by weight when compared to the total weight of the composition.
  4. Detergent composition according to any one of the claims 1 through 3, characterized by the fact that it has an amylase content of between 0.05 and 2% by weight when compared to the total weight of the composition.
  5. Detergent composition according to any one of the claims 1 through 4, characterized by the fact that the biodegradable chelating agent is methyl glycine diacetic acid.
  6. Detergent composition according to any one of the claims 1 through 5, characterized by the fact that it has a biodegradable chelating agent content of between 10 and 50% by weight when compared to the total weight of the composition.
  7. Detergent composition according to any one of the claims 1 through 6, characterized by the fact that it likewise comprises glycerin.
  8. Detergent composition according to any one of the claims 1 through 7, characterized by the fact that it likewise comprises one or a plurality of non-ionic surfactants.
  9. Use of a concentrated aqueous detergent composition according to any one of the preceding claims for the cleaning of surgical and/or medical instruments in a washer-disinfector.
  10. Use according to claim 9, characterized by the fact that the cleaning is carried out at a temperature of between 20 and 60Ā°C.
  11. Use according to claim 9 or 10, characterized by the fact that the cleaning time period is between 20 seconds and 10 minutes.
EP17716972.9A 2016-03-23 2017-03-23 Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices Active EP3433349B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL17716972T PL3433349T3 (en) 2016-03-23 2017-03-23 Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1652498A FR3049285B1 (en) 2016-03-23 2016-03-23 DETERGENT ENZYMATIC COMPOSITIONS FOR THE AUTOMATIC CLEANING OF SURGICAL AND / OR MEDICAL INSTRUMENTS AND / OR DEVICES.
PCT/FR2017/050684 WO2017162991A1 (en) 2016-03-23 2017-03-23 Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices

Publications (2)

Publication Number Publication Date
EP3433349A1 EP3433349A1 (en) 2019-01-30
EP3433349B1 true EP3433349B1 (en) 2020-04-22

Family

ID=56263860

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17716972.9A Active EP3433349B1 (en) 2016-03-23 2017-03-23 Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices

Country Status (4)

Country Link
EP (1) EP3433349B1 (en)
FR (1) FR3049285B1 (en)
PL (1) PL3433349T3 (en)
WO (1) WO2017162991A1 (en)

Family Cites Families (4)

* Cited by examiner, ā€  Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741355B1 (en) * 1995-11-17 1998-12-31 Anios Lab Sarl COMPOSITION FOR THE TREATMENT OF OBJECTS TO BE CLEANED AND / OR DISINFECTED
US7491362B1 (en) * 2008-01-28 2009-02-17 Ecolab Inc. Multiple enzyme cleaner for surgical instruments and endoscopes
US7723281B1 (en) * 2009-01-20 2010-05-25 Ecolab Inc. Stable aqueous antimicrobial enzyme compositions comprising a tertiary amine antimicrobial
FR2980955B1 (en) * 2011-10-05 2014-12-12 Anios Lab Sarl DISINFECTANT AND DETERGENT COMPOSITIONS.

Non-Patent Citations (1)

* Cited by examiner, ā€  Cited by third party
Title
None *

Also Published As

Publication number Publication date
WO2017162991A1 (en) 2017-09-28
FR3049285A1 (en) 2017-09-29
PL3433349T3 (en) 2020-10-19
WO2017162991A9 (en) 2018-10-11
EP3433349A1 (en) 2019-01-30
FR3049285B1 (en) 2018-04-13

Similar Documents

Publication Publication Date Title
JP5407002B2 (en) Cleaning composition for medical instrument washer
CN112292442B (en) Enzyme detergent for pan
US20080271760A1 (en) Method and Composition
JP2009149777A (en) Detergent composition for dish washer and method for producing the same
US9133424B2 (en) Stabilization and activation of protease for use at high temperature
JP6732454B2 (en) Cleaning disinfectant composition
KR102001696B1 (en) Liquid cleaning compositions with improved enzyme compatibility and/or stability
EP2588420B1 (en) Descaling of oxalates with acid compositions
JP2001501244A (en) Surface cleaner
KR101900978B1 (en) Liquid cleaning agent composition
CN105907483A (en) Oxygen-containing multifunctional detergent composition
JP7315948B2 (en) Disinfectant detergent composition
JP2009019130A (en) Detergent composition and deterging method of dishes using the same
EP3433349B1 (en) Enzymatic detergent compositions for the automatic cleaning of surgical and/or medical instruments and/or devices
JP6864339B2 (en) Cleaning agent composition for automatic washing machine
BE1027322B1 (en) Cleaning and degreasing composition for the treatment of hard surfaces
EP2970831B1 (en) Enzyme-containing detergent and presoak composition and methods of using
CN110546248A (en) Formulations and methods for cryogenic cleaning of dairy equipment
WO2022250123A1 (en) Method for promoting enzymatic reaction
EP3411464B1 (en) Detergent compositions for cleaning in the cosmetic and pharmaceutical industry
JP4973835B2 (en) Detergent for food processing
JP3779062B2 (en) Beer dispenser cleaning composition and cleaning method
WO2022270458A1 (en) Dish washing method
FR3066376A1 (en) WET DETERGENT WIPES
JP2024169588A (en) Starch stain adhesion inhibitor

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180924

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20191127

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: FRENCH

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602017015228

Country of ref document: DE

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1260072

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200515

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20200422

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 602017015228

Country of ref document: DE

Representative=s name: GODEMEYER BLUM LENZE PATENTANWAELTE, PARTNERSC, DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200822

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200722

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200723

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200824

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1260072

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200422

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200722

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602017015228

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20210125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20210331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210323

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210331

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210323

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20170323

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20231229

Year of fee payment: 8

Ref country code: GB

Payment date: 20240108

Year of fee payment: 8

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: PL

Payment date: 20240119

Year of fee payment: 8

Ref country code: IT

Payment date: 20240212

Year of fee payment: 8

Ref country code: FR

Payment date: 20240103

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200422